STE Valuation

STERIS plc

Add to Watchlist

Advanced Chart

230.460

+3.21(1.413%)1D

Overview
Forecast
Valuation
Earnings

STE Relative Valuation

STE's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, STE is overvalued; if below, it's undervalued.

Historical Valuation

STERIS plc (STE) is now in the Undervalued zone, suggesting that its current forward PE ratio of 22.63 is considered Undervalued compared with the five-year average of 24.94. The fair price of STERIS plc (STE) is between 247.17 to 290.11 according to relative valuation methord. Compared to the current price of 230.46 USD , STERIS plc is Undervalued By 6.76%.

Relative Value

Fair Zone

247.17-290.11

Current Price：230.46

6.76%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

3.38

P/B

Median3y

3.36

Median5y

3.54

3.48

FCF Yield

Median3y

2.61

Median5y

2.46

Competitors Valuation Multiple

The average P/S ratio for STE's competitors is 4.54, providing a benchmark for relative valuation. STERIS plc Corp (STE) exhibits a P/S ratio of 3.84, which is -15.45% above the industry average. Given its robust revenue growth of 32.65%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap